Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
5 employees
US-based CDI Bioscience develops commercial-grade bioproducts and offers cell line engineering services globally.
HQ
Founded
2007
CDI Bioscience, based in Madison, United States, develops technology for producing commercial-grade bioproducts. The company offers cell line engineering and clone isolation services, targeting healthcare providers and facilities worldwide.
CDI Bioscience has made significant strides in bioproduct development, impacting global healthcare markets. Their innovative solutions in cell line engineering have positioned them as a key player in the biotechnology industry.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Bioproducts, Cell Engineering
Technology
Biotech
Model Types
Software, Services
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was CDI Bioscience founded?
CDI Bioscience was founded in 2007.
Where is CDI Bioscience's headquarters located?
CDI Bioscience's headquarters is located in Madison, US.
When was CDI Bioscience's last funding round?
CDI Bioscience's most recent funding round was for $3M (USD) in December 2007.
How many employees does CDI Bioscience have?
CDI Bioscience has 5 employees as of Feb 4, 2024.
How much has CDI Bioscience raised to-date?
As of July 05, 2023, CDI Bioscience has raised a total of $3M (USD) since Dec 10, 2007.
Add Comparison
Total Raised to Date
$3M
USD
Last Update Dec 10, 2007
Last Deal Details
$3M
USD
Dec 10, 2007
Series Unknown
Current Employees
5
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts